CRISPR Therapeutics AG

Insiders Updates

CRISPR Therapeutics AG’s recent filing unveils that its Chief Operating Officer Bruno Julianne unloaded Company’s shares for reported $0.19 million

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics

Insiders Updates

CRISPR Therapeutics AG’s recently made public that its Chief Operating Officer Bruno Julianne unloaded Company’s shares for reported $0.19 million

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics

Insiders Updates

In a filing, CRISPR Therapeutics AG revealed its Chief Operating Officer Bruno Julianne unloaded Company’s shares for reported $0.19 million

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics

Analysts Viewpoint

CRISPR Therapeutics AG’s filing revealed that its Chief Operating Officer Bruno Julianne unloaded Company’s shares for reported $0.19 million on

Analysts Viewpoint

CRISPR Therapeutics AG’s filing revealed that its Chief Operating Officer Bruno Julianne unloaded Company’s shares for reported $0.19 million on

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

CRISPR Therapeutics AG’s recently made public that its Chief Operating Officer Bruno Julianne unloaded Company’s shares for reported $0.19 million

Tag: CRISPR Therapeutics AG